Maximising Your mRNA Characterisation to Ensure Safety, Efficacy & Quality of mRNA Therapeutics

Time: 12:30 pm
day: Conference Day One


  • Reviewing the instrumentation breakthroughs that have advanced mRNA characterisation, allowing for more accurate analysis and overcoming issues related to sensitisation
  • Exploring nuclear pore characterisation and how you can control the difference in formulation and heterogeneity of your nanoparticles once administered in the body
  • Exploring the latest advances in secondary structure characterisation and how this can optimise its efficacy and safety